Developer docs
API playgroundTry for free, no card

Search company profiles

Invenfin

Full company profile

uuid00054kj

Namestring
Invenfin
Legal namestring
Invenfin
Websiteurl
invenfin.com
Company typeenum
Private
Founded yearint
2011
Descriptiontext

Invenfin is the venture and growth capital division of Remgro, a South African diversified investment holding company. Established in 2011 and headquartered in Stellenbosch, Invenfin invests directly off Remgro's corporate balance sheet in technology, consumer, and healthcare businesses that have meaningful market traction, are aligned with fundamental global trends, and have potential to reach significant scale. Unlike conventional venture capital structures, the firm operates as a long-term investor without the constraints of a limited fund life, distinguishing it from time-pressured fund managers. Deal sourcing is relationship-driven, and Invenfin positions itself as an active partner providing mentorship, strategic guidance, and governance rather than a passive capital provider.

The portfolio comprises 17 companies spanning multiple sectors and geographies, including fintech (Float card-linked instalments, Money Fellows Egyptian money circles, Root embedded insurance), health tech (LifeQ wearable biometrics, National HealthCare Group), HR and workforce tech (Wyzetalk frontline workforce, OfferZen talent marketplace), eCommerce and marketing tech (Samarkand China cross-border, Blue Robot social media automation), consumer brands (BOS Brands rooibos beverages, Joya confectionery, lelive skincare, Fieldbar cooler boxes), and technology platforms (ArcAqua ozone-based sanitisation, Bolt mobility). Realized exits include Ad Dynamo (12x multiple, sold to US-based Aleph in 2022), DC Foods (5.2x multiple, sold to a UK investment consortium in 2023), and a partial exit from Bolt ahead of the company's €600m Series F in January 2022, which returned more than the total invested capital at an 85% net IRR.

Invenfin's business model is equity ownership in portfolio companies, with returns generated through funding rounds and eventual exits rather than management fees. The firm does not raise external capital and is funded entirely by Remgro's balance sheet, giving it a structurally patient capital base. Portfolio companies gain access to Remgro's broader group networks across healthcare (Mediclinic), insurance (Discovery, OUTsurance), and telecommunications (Vodacom), as well as governance and strategic collaboration support throughout the investment lifecycle.

Short descriptiontext

Invenfin is the venture and growth capital division of South African investment holding company Remgro, deploying patient capital off its own balance sheet into 17 technology, consumer, and healthcare portfolio companies with global scaling potential.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersStellenbosch, South Africa
HQ citystring
Stellenbosch
HQ countrystring
South Africa
HQ regionstring
Africa
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
venture capital investing, growth capital investments, technology equity investing, consumer brand investments, portfolio company management
Industry1 code
PRIMARYFSANAHAK
Corporate Fintech / Insurtech CVC (Financial-services-led CVC)
NAICS code1 code
  • Portfolio Management and Investment Advice523940
SIC code1 code
  • Investment Advice6282
Product category
Venture and Growth Capital Investment
Social media profiles2 records
Cost components4 values
Personnel, Operations, Technology or R&D, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Invenfin provides growth and venture capital equity investments in technology, consumer, and healthcare businesses that have meaningful market traction and potential to reach significant scale. The firm invests off its own balance sheet as a long-term partner, offering portfolio companies access to deep capital, mentorship, strategic guidance, and collaboration opportunities across the broader Remgro group. Returns are generated through equity ownership, funding rounds, and exits rather than external fund management fees.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Invenfin is the venture and growth capital division of Remgro, backing ambitious founders building fast-growing businesses in future industries. The portfolio comprises 17 companies across technology, consumer, and healthcare sectors. Exited investments include Ad Dynamo (12x multiple, Africa\'s largest digital media reseller representing Twitter, Spotify, Snapchat, Verizon Media), DC Foods (5.2x multiple, frozen fruit producer), and partial stake in Bolt (85% net IRR, mobility platform). Current portfolio spans fintech (Float card-linked instalments, Money Fellows Egyptian money circles, Root embedded insurance), health tech (LifeQ wearable biometrics, National HealthCare Group), HR tech (Wyzetalk frontline workforce, OfferZen talent marketplace), eCommerce (Samarkand China cross-border, Blue Robot social media automation), consumer brands (BOS Brands rooibos beverages, Joya confectionery, lelive skincare, Fieldbar cooler boxes), and technology (ArcAqua ozone sanitisation).

Product and service1 record
1Growth and Venture Capital Investment Services
CategoryVenture and Growth Capital Investment
Description

Long-term equity capital and active partnership provided to founders and management teams of technology, consumer, and healthcare businesses with meaningful market traction and potential to reach significant scale, deploying patient capital from Remgro's balance sheet.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Naspers Foundry is the corporate venture capital arm of Naspers focused on South African and emerging-market early-stage technology investments. Highly comparable as a large CVC vehicle targeting the same SA tech founder pool as Invenfin.

TypeDirect peer
Description

South African venture capital firm investing in growth-stage technology businesses. Operates in the same South African market, with similar focus on technology-enabled scale-up companies.

TypeDirect peer
Description

Early-stage technology venture capital firm based in Cape Town. Directly comparable as a SA-based tech VC investing in similar stage and sector of companies.

TypeDirect peer
Description

South African venture capital firm providing early-stage funding to technology-driven startups. Comparable stage, geography, and sector focus.

5TLcom Capital
TypeDirect peer
Description

Africa-focused venture capital firm backing early to growth-stage tech companies across the continent. Directly comparable on stage, sector, and geographic focus, including investments in companies like Money Fellows.

TypeBroad incumbent
Description

Global venture capital firm with significant Africa-focused fund and active investor in African tech companies. Comparable as a larger incumbent operating in the same geography and stage.

7Futuregrowth Asset Management
TypeRegional player
Description

South African fixed-income and alternative investment manager. Comparable as a domestic investment vehicle deploying capital within South Africa, though focused on debt rather than equity venture investing.

8Ethos Private Equity
TypeBroad incumbent
Description

One of South Africa's largest private equity firms. Comparable as a large SA-based PE/VC operator deploying growth-stage capital into local businesses.

TypeEmerging player
Description

Africa-focused venture builder and investor that supports early-stage tech startups across the continent. Comparable as an emerging Africa-focused tech investor with overlapping deal sourcing.

TypeOthers
Description

Parent company of Invenfin and a major South African diversified investment holding group. Included as the corporate parent that anchors Invenfin's patient capital strategy.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment19 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Invenfin

Venture and Growth Capital Investmentinvenfin.com

Invenfin is the venture and growth capital division of South African investment holding company Remgro, deploying patient capital off its own balance sheet into 17 technology, consumer, and healthcare portfolio companies with global scaling potential.

What Invenfin does

Invenfin is the venture and growth capital division of Remgro, a South African diversified investment holding company. Established in 2011 and headquartered in Stellenbosch, Invenfin invests directly off Remgro's corporate balance sheet in technology, consumer, and healthcare businesses that have meaningful market traction, are aligned with fundamental global trends, and have potential to reach significant scale. Unlike conventional venture capital structures, the firm operates as a long-term investor without the constraints of a limited fund life, distinguishing it from time-pressured fund managers. Deal sourcing is relationship-driven, and Invenfin positions itself as an active partner providing mentorship, strategic guidance, and governance rather than a passive capital provider.

The portfolio comprises 17 companies spanning multiple sectors and geographies, including fintech (Float card-linked instalments, Money Fellows Egyptian money circles, Root embedded insurance), health tech (LifeQ wearable biometrics, National HealthCare Group), HR and workforce tech (Wyzetalk frontline workforce, OfferZen talent marketplace), eCommerce and marketing tech (Samarkand China cross-border, Blue Robot social media automation), consumer brands (BOS Brands rooibos beverages, Joya confectionery, lelive skincare, Fieldbar cooler boxes), and technology platforms (ArcAqua ozone-based sanitisation, Bolt mobility). Realized exits include Ad Dynamo (12x multiple, sold to US-based Aleph in 2022), DC Foods (5.2x multiple, sold to a UK investment consortium in 2023), and a partial exit from Bolt ahead of the company's €600m Series F in January 2022, which returned more than the total invested capital at an 85% net IRR.

Invenfin's business model is equity ownership in portfolio companies, with returns generated through funding rounds and eventual exits rather than management fees. The firm does not raise external capital and is funded entirely by Remgro's balance sheet, giving it a structurally patient capital base. Portfolio companies gain access to Remgro's broader group networks across healthcare (Mediclinic), insurance (Discovery, OUTsurance), and telecommunications (Vodacom), as well as governance and strategic collaboration support throughout the investment lifecycle.

Invenfin firmographics

Firmographics
Name
Invenfin
Legal name
Invenfin
Website
https://invenfin.com
Company type
Private
Founded year
2011
Operating status
Operating
Headcount range
1–10 employees
Short description
Invenfin is the venture and growth capital division of South African investment holding company Remgro, deploying patient capital off its own balance sheet into 17 technology, consumer, and healthcare portfolio companies with global scaling potential.
Ownership category
akta.pro rank

Invenfin industry classification

Industry
Product category
Venture and Growth Capital Investment
NAICS
Portfolio Management and Investment Advice (523940)
SIC
Investment Advice (6282)
akta.pro industry
PRIMARYFSANAHAK
Corporate Fintech / Insurtech CVC (Financial-services-led CVC)

Keywords

  • Venture capital investing
  • Growth capital investments
  • Technology equity investing
  • Consumer brand investments
  • Portfolio company management

Where Invenfin is headquartered

Location

Headquarters

HQ city
Stellenbosch
HQ country
South Africa
HQ region
Africa

Offices1 record

Markets served

Invenfin business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Others

Invenfin product offering

Product offering

Core offering

Invenfin provides growth and venture capital equity investments in technology, consumer, and healthcare businesses that have meaningful market traction and potential to reach significant scale. The firm invests off its own balance sheet as a long-term partner, offering portfolio companies access to deep capital, mentorship, strategic guidance, and collaboration opportunities across the broader Remgro group. Returns are generated through equity ownership, funding rounds, and exits rather than external fund management fees.

Product overview

Invenfin is the venture and growth capital division of Remgro, backing ambitious founders building fast-growing businesses in future industries. The portfolio comprises 17 companies across technology, consumer, and healthcare sectors. Exited investments include Ad Dynamo (12x multiple, Africa\'s largest digital media reseller representing Twitter, Spotify, Snapchat, Verizon Media), DC Foods (5.2x multiple, frozen fruit producer), and partial stake in Bolt (85% net IRR, mobility platform). Current portfolio spans fintech (Float card-linked instalments, Money Fellows Egyptian money circles, Root embedded insurance), health tech (LifeQ wearable biometrics, National HealthCare Group), HR tech (Wyzetalk frontline workforce, OfferZen talent marketplace), eCommerce (Samarkand China cross-border, Blue Robot social media automation), consumer brands (BOS Brands rooibos beverages, Joya confectionery, lelive skincare, Fieldbar cooler boxes), and technology (ArcAqua ozone sanitisation).

Differentiator

Problem solved

Functional benefit

Products and services

  • Growth and Venture Capital Investment Services Long-term equity capital and active partnership provided to founders and management teams of technology, consumer, and healthcare businesses with meaningful market traction and potential to reach significant scale, deploying patient capital from Remgro's balance sheet.

Companies that use Invenfin

Customer profile

Segments1 record

Ideal customer profiles1 record

Invenfin technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Invenfin partnerships and signals

Strategic signal

Scale indicators5 records

Recent moves8 records

Expansion highlights5 records

Invenfin competitors and assessment

Company assessment

Direct peers

  • Naspers Foundry: Naspers Foundry is the corporate venture capital arm of Naspers focused on South African and emerging-market early-stage technology investments. Highly comparable as a large CVC vehicle targeting the same SA tech founder pool as Invenfin.
  • Knife Capital: South African venture capital firm investing in growth-stage technology businesses. Operates in the same South African market, with similar focus on technology-enabled scale-up companies.
  • 4Di Capital: Early-stage technology venture capital firm based in Cape Town. Directly comparable as a SA-based tech VC investing in similar stage and sector of companies.
  • Kalon Venture Partners: South African venture capital firm providing early-stage funding to technology-driven startups. Comparable stage, geography, and sector focus.
  • TLcom Capital: Africa-focused venture capital firm backing early to growth-stage tech companies across the continent. Directly comparable on stage, sector, and geographic focus, including investments in companies like Money Fellows.

Broad incumbents

  • Partech: Global venture capital firm with significant Africa-focused fund and active investor in African tech companies. Comparable as a larger incumbent operating in the same geography and stage.
  • Ethos Private Equity: One of South Africa's largest private equity firms. Comparable as a large SA-based PE/VC operator deploying growth-stage capital into local businesses.

Regional players

  • Futuregrowth Asset Management: South African fixed-income and alternative investment manager. Comparable as a domestic investment vehicle deploying capital within South Africa, though focused on debt rather than equity venture investing.

Emerging players

  • Founders Factory Africa: Africa-focused venture builder and investor that supports early-stage tech startups across the continent. Comparable as an emerging Africa-focused tech investor with overlapping deal sourcing.

Others

  • Remgro: Parent company of Invenfin and a major South African diversified investment holding group. Included as the corporate parent that anchors Invenfin's patient capital strategy.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Invenfin social profiles

Digital presence

Invenfin financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Invenfin leadership team

Management profile

Number of profiles

Profiles10 records

Invenfin funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Invenfin M&A and investment

M&A and investment

M&A

Investments19 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Invenfin

What does Invenfin do?

Invenfin provides growth and venture capital equity investments in technology, consumer, and healthcare businesses that have meaningful market traction and potential to reach significant scale. The firm invests off its own balance sheet as a long-term partner, offering portfolio companies access to deep capital, mentorship, strategic guidance, and collaboration opportunities across the broader Remgro group. Returns are generated through equity ownership, funding rounds, and exits rather than external fund management fees.

Is Invenfin a public or private company?

Invenfin is a private company. It is classified as corporate owned and is currently operating.

When was Invenfin founded?

Invenfin was founded in 2011. It employs 1 to 10 people.

Where is Invenfin based?

Invenfin is headquartered in Stellenbosch, South Africa, in the Africa region.

Who are Invenfin's main competitors?

Direct peers on record are Naspers Foundry, Knife Capital, 4Di Capital, Kalon Venture Partners and TLcom Capital. Broad incumbents are Partech and Ethos Private Equity. Futuregrowth Asset Management is listed as a regional player. Founders Factory Africa is listed as an emerging player. Remgro is listed as an others.

Does Invenfin have an API?

No public API is recorded for Invenfin.

What industry is Invenfin in?

Invenfin's product category is Venture and Growth Capital Investment. Its primary akta.pro industry code is FSANAHAK, Corporate Fintech / Insurtech CVC (Financial-services-led CVC). Its NAICS code is 523940 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
TechCabalFloat skipped Africa's expansion race to challenge UK’s fintech giantsFloat, a South African payments startup, expanded into the UK with its card-linked instalment product. The company has signed over 2,200 merchants in South Africa and raised R280 million. It targets shoppers with existing credit cards, avoiding new loans.Techgist AfricaRoot, a South African insurtech startup, secures $1.5M in fundingRoot Platform, a South African insurtech startup, has secured an additional US$1.5 million in funding from Invenfin to accelerate its international expansion. The capital will be used to grow operations in the UK and enter other European markets, leveraging Root's API-first insurance technology platform.DisruptafricaSA insurtech startup Root raises $1.5m to accelerate expansion plansRoot Platform, a South African insurtech startup, raised $1.5 million from Invenfin to accelerate its expansion in the UK and Europe. The funding follows a 2021 investment and will support its API-first insurance platform. The company aims to grow internationally as insurers seek embedded insurance channels.Disrupt-africaSA insurtech startup Root raises $1.5m to accelerate expansion plans – Old Disrupt AfricaSouth African insurtech startup Root Platform has secured an additional $1.5 million in funding from existing investor Invenfin to accelerate its expansion into the UK and European markets. The capital will support Root's strategy of providing API-first insurance technology to enable companies to build and deploy digital insurance products quickly.FfnewsRoot Accelerates Expansion Plans After Invenfin InvestmentRoot, an insurance technology platform provider, has secured a $1.5 million investment from Invenfin, the venture capital arm of Remgro Limited. This additional funding follows an initial investment in 2021 and is designated to accelerate Root's expansion into the UK and European markets. The company aims to leverage this capital to scale its low-code, API-first solutions for embedded insurance distribution.RootplatformPress Release: Root accelerates expansion plans after Invenfin investmentRoot Platform has announced an additional $1.5 million investment from Invenfin to accelerate its expansion plans in the UK and Europe. This follows a prior investment by Invenfin, and Root aims to leverage the funding to enhance its insurance technology offerings and market presence internationally. Root is positioning itself to capitalize on the growing demand for embedded insurance solutions in the insurance sector.VentureburnLuno and Invenfin back Root insurance API in $3m seed roundRoot, a Cape Town-based low-code insurance platform, closed a $3 million seed funding round led by primary backers Invenfin and Luno. The company intends to use the capital to expand its digital insurance infrastructure and API services to new regions following strong demand from existing South African partners like Telkom and Metropolitan.Disrupt-africaInvenfin acquires 20% stake in WyzeTalk – Old Disrupt AfricaInvenfin acquired a 20% stake in WyzeTalk, raising total investment past US$2 million. WyzeTalk has over 30,000 users and integrates with platforms like LinkedIn and Dropbox. The investment aims to accelerate scaling in emerging markets.VentureburnInvenfin grabs 20% stake in WyzeTalkInvenfin, the venture arm of Remgro, acquired a 20% stake in South African social business platform WyzeTalk. The investment brings WyzeTalk's total funding to over R20-million, including from the Kenyan Savannah Fund. WyzeTalk has over 30,000 users and plans to scale faster with institutional funding.